Background <p>Mechanically ventilated patients may experience respiratory suffering, which is difficult to assess when verbal communication is impaired. We evaluated the performance of a steady-state visual evoked potential (SSVEP)-based brain–computer interface (BCI) designed to enable self-reporting of dyspnoea in this context.</p> Methods <p>Forty-nine healthy volunteers were studied under five respiratory conditions: normal breathing (NB), inspiratory resistive loading (IRL), inspiratory threshold loading (ITL), CO₂ inhalation (CO₂), and a return to NB as wash-out (NBWO). Respiratory discomfort was evaluated using a visual analogue scale (VAS). Two BCIs models were tested: a detection BCI (D-BCI), designed to discriminate between ‘breathing is OK’ and ‘breathing is difficult’, and a quantification BCI in the form of a LED-based analogue scale (LAS), composed of five light-emitting diodes. Visual stimuli were delivered at different frequency sets: 12–15&#xa0;Hz, 15–20&#xa0;Hz, and 20–30&#xa0;Hz for the D-BCI; low frequencies (13–17–19–23–29&#xa0;Hz) and high frequencies (41–43–47–53–59&#xa0;Hz) for the LAS. Performance was assessed using receiver operating characteristic (ROC) curves; the area under the ROC curve (AUC) was the primary outcome.</p> Results <p>Participants reported significant respiratory discomfort during IRL, ITL, and CO₂ conditions in the D-BCI groups, and during ITL and CO₂ in the LAS groups, as reflected by higher dyspnoea VAS scores compared to NB. The best-performing frequency sets were 20–30&#xa0;Hz for the D-BCI (AUC 0.89 [0.89–0.90]) and low frequencies for the LAS (AUC 0.84 [0.83–0.85]).</p> Conclusions <p>This study demonstrates that an SSVEP-based BCI can sucessfully detect and quantify experimentally induced dyspnoea in healthy individuals. Further research is needed to evaluate its clinical applicability for assessing dyspnoea in non-communicative patients.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

SSVEP-based brain–computer interface enabling graded dyspnoea self-report: proof-of-concept study in healthy volunteers

  • Sébastien Campion,
  • Xavier Navarro-Suné,
  • Isabelle Rivals,
  • Capucine Morélot-Panzini,
  • Laure Serresse,
  • Mario Chavez,
  • Alexandre Demoule,
  • Marie-Cécile Niérat,
  • Mathieu Raux,
  • Thomas Similowski

摘要

Background

Mechanically ventilated patients may experience respiratory suffering, which is difficult to assess when verbal communication is impaired. We evaluated the performance of a steady-state visual evoked potential (SSVEP)-based brain–computer interface (BCI) designed to enable self-reporting of dyspnoea in this context.

Methods

Forty-nine healthy volunteers were studied under five respiratory conditions: normal breathing (NB), inspiratory resistive loading (IRL), inspiratory threshold loading (ITL), CO₂ inhalation (CO₂), and a return to NB as wash-out (NBWO). Respiratory discomfort was evaluated using a visual analogue scale (VAS). Two BCIs models were tested: a detection BCI (D-BCI), designed to discriminate between ‘breathing is OK’ and ‘breathing is difficult’, and a quantification BCI in the form of a LED-based analogue scale (LAS), composed of five light-emitting diodes. Visual stimuli were delivered at different frequency sets: 12–15 Hz, 15–20 Hz, and 20–30 Hz for the D-BCI; low frequencies (13–17–19–23–29 Hz) and high frequencies (41–43–47–53–59 Hz) for the LAS. Performance was assessed using receiver operating characteristic (ROC) curves; the area under the ROC curve (AUC) was the primary outcome.

Results

Participants reported significant respiratory discomfort during IRL, ITL, and CO₂ conditions in the D-BCI groups, and during ITL and CO₂ in the LAS groups, as reflected by higher dyspnoea VAS scores compared to NB. The best-performing frequency sets were 20–30 Hz for the D-BCI (AUC 0.89 [0.89–0.90]) and low frequencies for the LAS (AUC 0.84 [0.83–0.85]).

Conclusions

This study demonstrates that an SSVEP-based BCI can sucessfully detect and quantify experimentally induced dyspnoea in healthy individuals. Further research is needed to evaluate its clinical applicability for assessing dyspnoea in non-communicative patients.